| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.9M | +151.4% |
| Cost of Revenue | $9.4M | +160.7% |
| Gross Profit | $4.5M | +133.8% |
| R&D Expense | $4.1M | +2.9% |
| SG&A Expense | $10.0M | +40.1% |
| Operating Income | -$23.6M | -23.6% |
| Pre-tax Income | -$22.1M | -15.9% |
| Income Tax | -$12K | -102.6% |
| Net Income | -$22.1M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.1M | -58.6% |
| Accounts Receivable | $3.1M | +201.2% |
| Inventory | $5.7M | +93.0% |
| Current Assets | $39.2M | -45.9% |
| Total Assets | $63.2M | -14.9% |
| Current Liabilities | $11.8M | +146.7% |
| Total Liabilities | $16.7M | +174.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.7M | -15.5% |
| Capital Expenditures | $81K | +224.0% |
| Investing Cash Flow | -$18.1M | — |
| Financing Cash Flow | -$992K | +60.3% |
| Free Cash Flow | -$20.7M | -15.8% |
| -13.1% |
| EPS (Basic) | -$0.37 | -19.4% |
| EPS (Diluted) | -$0.37 | -19.4% |
| Stockholders' Equity |
| $46.5M |
| -31.8% |